NCT06165536View on ClinicalTrials.gov

Laryngeal and Vocal Tract Strategies to Reduce Vocal Fold Contact Pressure

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
Mid-membranous Vocal Fold Lesion
Interventions
BEHAVIORAL

Resonant voice therapy

Resonant voice therapy is a standard of care procedure for treating phonotraumatic vocal hyperfunction. The full standardized voice therapy program will have a duration of four weeks, each week with one 60-minute therapy session.

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

University of California, Los Angeles

OTHER

NCT06165536 - Laryngeal and Vocal Tract Strategies to Reduce Vocal Fold Contact Pressure | Biotech Hunter | Biotech Hunter